Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Apr-24 5:04 PM View:  | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 02-Apr-24 | Payment of Exercise | 444 | $182.95 | $81,229.80 | (2%) 21.04K to 20.59K | (15%) |
| 20-Mar-24 4:29 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 18-Mar-24 | Gift | 2,000 | -- | -- | (1%) 185.25K to 183.25K | |
| 19-Mar-24 6:19 PM View: | Pax Margaret Director | Repligen Corp. (RGEN) | 18-Mar-24 | Grant | 92 | -- | -- | 100% 0 to 92 | |
| 12-Mar-24 8:24 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 11-Mar-24 | Option Exercise | 1,271 | $86.10 | $109,433.00 | 5% 26.51K to 27.78K | |
| 12-Mar-24 8:24 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 11-Mar-24 | Option Sale | 1,271 | $193.73 | $246,231.00 | (5%) 27.78K to 26.51K | |
| 12-Mar-24 8:24 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 11-Mar-24 | Sale | 2,246 | $193.73 | $435,118.00 | (8%) 26.51K to 24.26K | |
| 11-Mar-24 7:43 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 08-Mar-24 | Option Sale | 1 | $197.44 | $197.44 | (< 1%) 201.96K to 201.96K | |
| 11-Mar-24 7:43 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 08-Mar-24 | Sale | 16,706 | $197.44 | $3,298,430.00 | (8%) 201.96K to 185.25K | |
| 11-Mar-24 7:43 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 08-Mar-24 | Option Exercise | 1 | $16.55 | $16.55 | < 1% 201.96K to 201.96K | |
| 07-Mar-24 4:28 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 07-Mar-24 | Payment of Exercise | 2,867 | $195.72 | $561,129.00 | (1%) 204.82K to 201.96K | (8%) |
| 07-Mar-24 4:23 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 07-Mar-24 | Payment of Exercise | 1,206 | $195.72 | $236,038.00 | (5%) 22.24K to 21.04K | (8%) |
| 07-Mar-24 4:27 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 07-Mar-24 | Payment of Exercise | 386 | $195.72 | $75,547.90 | (1%) 26.89K to 26.51K | (8%) |
| 07-Mar-24 4:22 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 07-Mar-24 | Payment of Exercise | 386 | $195.72 | $75,547.90 | (1%) 28.14K to 27.75K | (8%) |
| 06-Mar-24 10:00 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 05-Mar-24 | Payment of Exercise | 7,275 | $195.52 | $1,422,410.00 | (3%) 212.1K to 204.82K | (8%) |
| 06-Mar-24 10:00 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 05-Mar-24 | Payment of Exercise | 22 | $195.52 | $4,301.44 | (< 1%) 22.26K to 22.24K | (8%) |
| 06-Mar-24 10:00 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 04-Mar-24 | Payment of Exercise | 135 | $193.99 | $26,188.70 | (< 1%) 27.03K to 26.89K | (9%) |
| 04-Mar-24 9:45 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 04-Mar-24 | Payment of Exercise | 461 | $192.71 | $88,839.30 | (2%) 28.73K to 28.27K | |
| 06-Mar-24 10:00 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 04-Mar-24 | Payment of Exercise | 1,111 | $193.99 | $215,523.00 | (< 1%) 213.21K to 212.1K | (9%) |
| 06-Mar-24 10:00 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 04-Mar-24 | Payment of Exercise | 197 | $193.99 | $38,216.00 | (< 1%) 22.46K to 22.26K | (9%) |
| 04-Mar-24 9:51 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 01-Mar-24 | Payment of Exercise | 453 | $191.79 | $86,880.90 | (2%) 27.48K to 27.03K | |
| 04-Mar-24 9:45 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 01-Mar-24 | Payment of Exercise | 447 | $191.79 | $85,730.10 | (2%) 29.18K to 28.73K | |
| 04-Mar-24 9:49 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 01-Mar-24 | Payment of Exercise | 3,322 | $191.79 | $637,126.00 | (2%) 216.53K to 213.21K | |
| 04-Mar-24 9:45 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 01-Mar-24 | Payment of Exercise | 820 | $191.79 | $157,268.00 | (4%) 23.23K to 22.41K | |
| 05-Mar-24 8:44 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 01-Mar-24 | Grant | 50 | -- | -- | < 1% 22.41K to 22.46K | |
| 04-Mar-24 9:45 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 29-Feb-24 | Grant | 404 | -- | -- | 2% 22.83K to 23.23K | |
| 04-Mar-24 9:51 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 29-Feb-24 | Grant | 404 | -- | -- | 1% 27.08K to 27.48K | |
| 04-Mar-24 9:45 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 29-Feb-24 | Grant | 391 | -- | -- | 1% 28.79K to 29.18K | |
| 04-Mar-24 9:49 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 29-Feb-24 | Grant | 2,504 | -- | -- | 1% 214.03K to 216.53K | |
| 29-Feb-24 7:09 PM View: | Garland Jason K CFO | Repligen Corp. (RGEN) | 27-Feb-24 | Grant | 2,540 | -- | -- | 46% 5.5K to 8.04K | |
| 29-Feb-24 9:25 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 27-Feb-24 | Grant | 8,691 | -- | -- | 61% 14.13K to 22.83K | |
| 29-Feb-24 8:54 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 27-Feb-24 | Grant | 3,520 | -- | -- | 15% 23.56K to 27.08K | |
| 28-Feb-24 9:56 PM View: | Dawes Karen A Director | Repligen Corp. (RGEN) | 27-Feb-24 | Option Exercise | 4,626 | $42.07 | $194,616.00 | 6% 83.74K to 88.37K | |
| 29-Feb-24 9:04 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 27-Feb-24 | Grant | 19,719 | -- | -- | 10% 194.31K to 214.03K | |
| 28-Feb-24 9:56 PM View: | Dawes Karen A Director | Repligen Corp. (RGEN) | 27-Feb-24 | Option Sale | 1,000 | $193.35 | $193,350.00 | (1%) 88.37K to 87.37K | |
| 29-Feb-24 7:07 PM View: | Loeillot Olivier President and CCO | Repligen Corp. (RGEN) | 27-Feb-24 | Grant | 2,880 | -- | -- | 22% 12.91K to 15.79K | |
| 26-Feb-24 8:38 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 23-Feb-24 | Sale | 3,433 | $198.08 | $680,009.00 | (20%) 17.57K to 14.13K | |
| 26-Feb-24 8:38 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 23-Feb-24 | Option Exercise | 940 | $94.33 | $88,670.20 | 5% 17.57K to 18.51K | |
| 26-Feb-24 8:38 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 23-Feb-24 | Option Sale | 940 | $198.08 | $186,195.00 | (5%) 18.51K to 17.57K | |
| 16-Nov-23 4:05 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 14-Nov-23 | Gift | 1,000 | -- | -- | (< 1%) 195.31K to 194.31K | |
| 13-Nov-23 5:10 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 10-Nov-23 | Sale | 3,788 | $147.13 | $557,328.00 | (12%) 32.58K to 28.79K | |
| 03-Oct-23 10:00 PM View: | Loeillot Olivier President and CCO | Repligen Corp. (RGEN) | 02-Oct-23 | Grant | 12,906 | -- | -- | 100% 0 to 12.91K | |
| 27-Sep-23 5:51 PM View: | Garland Jason K CFO | Repligen Corp. (RGEN) | 25-Sep-23 | Grant | 5,503 | -- | -- | 100% 0 to 5.5K | |
| 30-Aug-23 4:06 PM View: | Dawes Karen A Director | Repligen Corp. (RGEN) | 29-Aug-23 | Option Sale | 850 | $171.38 | $145,673.00 | (1%) 84.59K to 83.74K | |
| 30-Aug-23 4:06 PM View: | Dawes Karen A Director | Repligen Corp. (RGEN) | 29-Aug-23 | Option Exercise | 7,392 | $18.12 | $133,943.00 | 10% 77.2K to 84.59K | |
| 22-May-23 9:48 PM View: | Madaus Martin D Director | Repligen Corp. (RGEN) | 18-May-23 | Grant | 686 | -- | -- | 42% 1.62K to 2.31K | |
| 22-May-23 9:36 PM View: | Mhatre Rohin Director | Repligen Corp. (RGEN) | 18-May-23 | Grant | 686 | -- | -- | 41% 1.66K to 2.35K | |
| 22-May-23 9:21 PM View: | Barthelemy Nicholas Director | Repligen Corp. (RGEN) | 18-May-23 | Grant | 686 | -- | -- | 33% 2.08K to 2.77K | |
| 22-May-23 9:21 PM View: | Muir Glenn P Director | Repligen Corp. (RGEN) | 18-May-23 | Grant | 686 | -- | -- | 10% 6.9K to 7.58K | |
| 22-May-23 9:26 PM View: | Dawes Karen A Director | Repligen Corp. (RGEN) | 18-May-23 | Grant | 798 | -- | -- | 1% 76.4K to 77.2K | |
| 22-May-23 9:19 PM View: | Konstantinov Konstantin Director | Repligen Corp. (RGEN) | 18-May-23 | Grant | 686 | -- | -- | 128% 0.53K to 1.22K |
